BridgeMD
EFFECT OF DEXAMETASONE ON LOWER LIMB EDEMA IN PATIENTS UNDERTAKEN FOR TOTAL HIP ARTHROPLASTY
EU CTIS ID: 2024-518133-28-00
What this study is testing
Evaluate the anti-inflammatory role of dexamethasone in reducing postoperative edema in patients undergoing total hip arthroplasty
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Men and women aged 30-80 years
- Patients that undergo primary total hip replacement
- Diagnosis of primary hip osteoarthritis
- Accept and sign the informed consent
You likely can't join if
- Patient undergoing corticosteroid treatment during the last 6 months before surgery
- Patients diagnosed with previous lymphedema
- Patients with alterations of the cortico-adrenal axis
- Any condition that, in the clinical judgment of the researchers, may interfere with the object of the research
- Patients with a diagnosis of secondary osteoarthritis of the hip
- Patients with a diagnosis of hip fracture
See the full eligibility criteria
- Men and women aged 30-80 years
- Patients that undergo primary total hip replacement
- Diagnosis of primary hip osteoarthritis
- Accept and sign the informed consent
- Patient undergoing corticosteroid treatment during the last 6 months before surgery
- Patients diagnosed with previous lymphedema
- Patients with alterations of the cortico-adrenal axis
- Any condition that, in the clinical judgment of the researchers, may interfere with the object of the research
- Patients with a diagnosis of secondary osteoarthritis of the hip
- Patients with a diagnosis of hip fracture
- Allergic patients to Dexamethasone
- Patients who meet the criteria for malnutrition
- Patient with a diagnosis of Diabetes Mellitus (DM1 and DM2)
- Patients with Congestive Heart Failure (CHF)
- Patients with Chronic Renal Insufficiency (eGFR<60).
- Patients with peripheral venous insufficiency
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.